Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples